Literature DB >> 25251768

Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care: a qualitative study.

A Zafar1, M A Stone, M J Davies, K Khunti.   

Abstract

AIMS: Failure to intensify treatment in patients with Type 2 diabetes with suboptimal blood glucose control has been termed clinical inertia and has been shown to contribute to poorer patient outcomes. We aimed to identify and explore perceptions about clinical inertia from the perspective of primary healthcare providers.
METHODS: A qualitative study was conducted in Leicestershire and Northamptonshire, UK. Purposive sampling was based on healthcare providers working in primary care settings with 'higher' and 'lower' target achievement based on routine data. Twenty semi-structured interviews were conducted, face-to-face or by telephone. Thematic analysis was informed by the constant comparative approach.
RESULTS: An important broad theme that emerged during the analysis was related to attribution and explanation of responsibility for clinical inertia. This included general willingness to accept a degree of responsibility for clinical inertia. In some cases, however, participants had inaccurate perceptions about levels of target achievement in their primary care centres, as indicated by routine data. Participants sought to lessen their own sense of accountability by highlighting patient-level barriers such as comorbidities and human fallibility, and also system-level barriers, particularly time constraints. Perceptions about ways of addressing the problem of clinical inertia were not seen as straightforward, further emphasizing a complex and cumulative pattern of barriers.
CONCLUSIONS: In order to understand and address the problem of clinical inertia, provider, patient- and system-level barriers should be considered together rather than as separate issues. Acknowledgement of responsibility should be regarded positively as a motivator for change.
© 2014 The Authors. Diabetic Medicine © 2014 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25251768     DOI: 10.1111/dme.12592

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  30 in total

Review 1.  Quality of Diabetes Care in the USA.

Authors:  Ben Alencherry; Dennis Bruemmer
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

2.  12th Roche Diabetes Care Network Meeting: April 11-13, 2019, Copenhagen, Denmark.

Authors:  Christopher G Parkin; Christine Zepezauer; Rolf Hinzmann
Journal:  Diabetes Technol Ther       Date:  2020-01-14       Impact factor: 6.118

3.  A Behavioral Perspective of Therapeutic Inertia: A Look at the Transition to Insulin Therapy.

Authors:  Susan J Guzman
Journal:  Diabetes Spectr       Date:  2020-02

4.  Therapeutic Inertia: Still a Long Way to Go That Cannot Be Postponed.

Authors:  Manel Mata-Cases; Josep Franch-Nadal; Mònica Gratacòs; Dídac Mauricio
Journal:  Diabetes Spectr       Date:  2020-02

5.  The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction.

Authors:  Moshe Phillip; Richard M Bergenstal; Kelly L Close; Thomas Danne; Satish K Garg; Lutz Heinemann; Irl B Hirsch; Boris P Kovatchev; Lori M Laffel; Viswanathan Mohan; Christopher G Parkin; Tadej Battelino
Journal:  Diabetes Technol Ther       Date:  2020-09-28       Impact factor: 6.118

6.  Optimizing Therapeutic Outcomes With Oral Semaglutide: A Patient-Centered Approach.

Authors:  Diana M Isaacs; Davida F Kruger; Geralyn R Spollett
Journal:  Diabetes Spectr       Date:  2021-01

7.  Changes in diabetes medication regimens and glycemic control in adolescents and young adults with youth-onset type 2 diabetes: The SEARCH for diabetes in youth study.

Authors:  Cathy A Pinto; Jeanette M Stafford; Tongtong Wang; R Ravi Shankar; Jean M Lawrence; Grace Kim; Catherine Pihoker; Ralph B D'Agostino; Dana Dabelea
Journal:  Pediatr Diabetes       Date:  2018-06-13       Impact factor: 3.409

8.  Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey.

Authors:  Michel Krempf; Ross J Simpson; Dena Rosen Ramey; Philippe Brudi; Hilde Giezek; Joanne E Tomassini; Raymond Lee; Michel Farnier
Journal:  Lipids Health Dis       Date:  2015-05-19       Impact factor: 3.876

9.  Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary care.

Authors:  Roopa Mehta; Ronald Goldenberg; Daniel Katselnik; Louis Kuritzky
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

10.  Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.

Authors:  K Khunti; A Nikolajsen; B L Thorsted; M Andersen; M J Davies; S K Paul
Journal:  Diabetes Obes Metab       Date:  2016-02-09       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.